Burgwedel, Germany

Rainer Blasczyk

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Other. Active years: 2015.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,307 
Other
 patents

Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rainer Blasczyk: Innovator in T-Cell Stimulating Protein Fragments

Introduction

Rainer Blasczyk is a notable inventor based in Burgwedel, Germany. He has made significant contributions to the field of immunology, particularly in the identification of T-cell stimulating protein fragments. His innovative methods have the potential to enhance immunostimulation therapies.

Latest Patents

Rainer Blasczyk holds a patent for a method for identifying T-cell stimulating protein fragments. The invention involves several steps, including detecting the amino acid sequence of an antigen, subdividing the sequence into protein fragments, synthesizing these fragments, and incubating them with T-cells. The process culminates in identifying induced T-cell cytokines or activation markers through flow-through cytometry. This method allows for the synthetic production of corresponding protein fragments, which can be utilized in developing medicaments for immunostimulation. He has 1 patent to his name.

Career Highlights

Throughout his career, Rainer Blasczyk has worked with various organizations, including Imusyn GmbH Co. Kg. His expertise in immunology and protein synthesis has positioned him as a valuable contributor to advancements in medical science.

Collaborations

Rainer has collaborated with notable professionals in his field, including Alexander Scheffold and Hans-Dieter Volk. These collaborations have further enriched his research and development efforts.

Conclusion

Rainer Blasczyk's innovative work in identifying T-cell stimulating protein fragments showcases his commitment to advancing immunological therapies. His contributions are paving the way for new treatments that could significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…